Future ameloblastoma studies in the United States can incorporate genetic analysis, which may shed insight into how the BRAF V600E mutation can affect the development and recurrence of ameloblastomas in multi- and mixed-racial populations. The gene discussed is BRAF; the disease is ameloblastoma.